The report helps businesses gain a unique insight into the socio-economic dynamics, and helps analyze how they affect healthcare systems and their evolution. It can serve as a valuable tool with actionable guidance for sales, marketing, R&D and business managers with industry related interests.
Four chapters cover the numerical and written analysis for the following topics: Economic Outlook (38 Key industry indicators), The Healthcare System (HC system structures), Reforms (restructuring, re-engineering or austerity efforts) and the Healthcare Market (Capital Equipment, Medical Devices, Disposables and Pharmaceuticals).
The TforG report is accessible through a user friendly Business Intelligence tool. Licenses are valid for 1 year.
- The Czech Republic is a landlocked nation in East-Central Europe bordering Germany, Poland, Slovakia and Austria with a population of 10.5 m.
- The Czech economy has performed strongly in the last year and in 2016 the nominal GDP is estimated at €160 bn. Annual GDP growth is 3%.
- It is well integrated with the EU market, and is susceptible to the performance of its trading partners, fore mostly the EU, and Germany in particular.
- Private domestic demand and EU-backed public investments strongly supported the comeback from a contraction in 2012. Enhanced financial policies improving the conditions for businesses, a growth in wages and revenues, along with increased export demand, will continue to push economic Czech growth in the next 5 years.
The Healthcare System:
- Czech healthcare expenditure in 2016 as a percentage of GDP is estimated at 7.75%. GDP per capita is €1,177.
- Universal coverage is provided through 8 public health insurance funds, offering a wide package of benefits and yielding positive health status outcomes, financed by a mandatory social contribution scheme.
- Around 50% of healthcare expenditure is spent on hospital care, including in- and outpatient services, long-term hospitalization and, for example, spa treatments.
- There are 14 regional public health authorities at a regional level. These are instructed by the MoH.
- There are approximately 5,330 general practitioners and 4,445 primary care centers. The total number of acute hospitals is 156.
- Child mortality is on par with Germany’s. Average life expectancy is around 78.8 years.
- A trend over the last 5 years has shown that smaller hospitals are dedicating more resources and re-organization to serve outpatient services, and to reduce inpatient care.
- Annual insurance fund activity costs decreased (2015)
- Abolishment of user fees (2013-2015)
- Reduced VAT for pharmaceuticals (2015)
- Commission for Assessment of Allocation of Medical Devices (2014)
- Central purchasing (2014)
- DRG Restart (2014)
- Cross-border healthcare reimbursement (2014)
- National Reform Program (2013)
- The Czech Republic spent €12.3 bn in 2015 on its domestic healthcare market, equal to close to 8% of its GDP. By 2017 it is forecasted to be worth around €12.5 bn.
- The medical device market is valued around €1.43 bn. The pharmaceutical market value is close to €2 bn. The capital equipment market is valued around €1.6 bn and its medical disposables market is valued at €196 m.
- 75% of medical devices and products used in the Czech healthcare system are imported.
- Procurement is managed centrally per hospital and tenders are popular.
- Principle drivers shaping the healthcare policies and the healthcare market in the Czech Republic at the moment concern the fiscal challenges and process inefficiencies.
Includes tables centralizing all relevant data on socio-demographics, macroeconomics and national Healthcare.
National Care Provision data:
Provides an overview of the Healthcare demographics: Nation Care provision data, Intensive Care units, Operating rooms, Emergency Rooms, Hospital services, Healthcare professionals.
© TforG Group – All Rights Reserved.